[Early detection and follow-up of solid tumors]. / Früherfassung und Verlaufskontrolle solider Tumoren.
Z Gesamte Inn Med
; 42(1): 14-7, 1987 Jan 01.
Article
em De
| MEDLINE
| ID: mdl-3577262
ABSTRACT
The early recognition of solid tumours as presymptomatic diagnostics is only reasonable, when it leads to a gain of survival time and survival rate. The evidence of effectiveness by randomized studies (apart from carcinoma of the cervix) was proved up to now only for the carcinoma of the breast (mammography) and the carcinoma of the colon (occult blood in the stools). The target-specific screening within well defined risk groups is to be recommended, when the subsequent chain of investigations and the therapy chain is ascertained. For the control of the course increasingly tumour markers are used including monoclonal antibodies against tumour-associated antigens.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Programas de Rastreamento
/
Neoplasias
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limite:
Female
/
Humans
Idioma:
De
Ano de publicação:
1987
Tipo de documento:
Article